Pearson: Valeant/Bausch + Lomb innovation pathway not mired by preconceived budgets, organic growth demands

SAN DIEGO - Valeant approaches innovation with the concept “the best idea wins” vs. the approach of other companies that their projects “are better no matter what,” said J. Michael Pearson, chairman and CEO of Valeant Pharmaceuticals, during his plenary talk, here at the Ophthalmology Innovation Summit.Innovation is not created in large companies, he said. Pearson believes that the pathway to innovation is through universities, start-up companies and practicing physicians.